Ask AI
AGOC
Slides: INTEGRATE IIa: Randomised double-blind Phase III  study of regorafenib versus placebo in refractory  advanced Gastro-Oesophageal Cancer (AGOC).

Released: January 25, 2023

Activity

Progress
1
Course Completed